Target intelligence / Profile preview

Ral guanine nucleotide exchange factor with PH domain and SH3-binding motif 2 (RALGPS2)

Target
RALGPS2
Molecular classification
Enzyme, Guanine nucleotide exchange factor (GEF), Signal transduction protein, Other
01

Overview

Ral guanine nucleotide exchange factor with PH domain and SH3-binding motif 2 (RALGPS2) is a member of the guanine nucleotide exchange factor (GEF) family specifically activating the small GTPase RalA, but does not exhibit a Ras-binding domain[1][2][3]. RALGPS2 contains a Cdc25-like GEF domain, a central PxxP motif (allowing interactions with SH3 domains, such as those of Grb2 and phospholipase C gamma), and a C-terminal pleckstrin homology (PH) domain that binds phosphatidylinositol 4,5-bisphosphate and mediates membrane localization[1][2][3][4]. RALGPS2 is involved in cytoskeletal organization, causes morphological changes, and is essential for formation of tunneling nanotubes, which play roles in cell–cell communication relevant to cancer progression[4]. In cancer cell lines, RALGPS2 is necessary for cell survival and cell cycle progression, working partly independently of the canonical RalA/RalB GTPases, and influencing key cell cycle regulators such as Skp2, p27, and p21[6]. It is expressed in various tissues including testis, brain, and cancer cells[1][4]. RALGPS2 is considered a signaling protein with oncogenic relevance but is not currently associated with specific approved drugs or therapeutic targeting strategies[3][6].

Other names
RALGPS2KIAA0351FLJ10244FLJ25604dJ595C2.1Ras-specific guanine nucleotide-releasing factor RalGPS2RalA exchange factor RalGPS2Ral GEF with PH domain and SH3-binding motif 2
02

Biological functions

Signal transductionCytoskeletal organizationCell cycle regulationCell survivalTranscription regulationCell proliferationCell morphology regulation
03

Disease associations

CancerCell proliferation disordersPotential roles in cell migration/metastasis
04

Safety considerations

Potential for effects on cell proliferation and cytoskeleton dynamics if targetedpossible relevance to cancer progression and cell survival[6][4]

Beyond the preview

Go deeper on Ral guanine nucleotide exchange factor with PH domain and SH3-binding motif 2 (RALGPS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ral guanine nucleotide exchange factor with PH domain and SH3-binding motif 2 (RALGPS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call